Log In
BCIQ
Print this Print this
 

Nicotinic acetylcholine receptor alpha(3)beta(4)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Nicotinic acetylcholine receptor alpha(3)beta(4)

BCIQ
Print ChartPrint this
1 - Infectious 1 - Neurology
Phase of DevelopmentPreclinicalPhase I
Infectious

-

1

Neurology

1

-




 Products Targeting Nicotinic acetylcholine receptor alpha(3)beta(4)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$1,280.0M

$240.0M

$1,040.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/20/2015

$40.0M

$40.0M

0

12/07/2009

$1,240.0M

$200.0M

$1,040.0M

Get a free BioCentury Trial today